Pravastatin
Back to searchMolecule Structure
Scientific Name
Pravastatin
Description of the Drug
Pravastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and to reduce the risk of cardiovascular events, including myocardial infarction and stroke.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00175
http://www.drugbank.ca/drugs/DB00175
Brand Name(s)
Not Available
Company Owner(s)
Cipla Ltd, Bristol Myers Squibb, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Hisun Pharmaceutical Hangzhou Co Ltd, Teva Pharmaceuticals Usa Inc, Biocon Pharma Inc, Accord Healthcare Inc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| HMG-CoA reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL402 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1117 | ||
| PharmGKB | PA451089 | ||
| Human Metabolome Database | HMDB0005022 | ||
| DrugBank | DB00175 | ||
| PubChem: Thomson Pharma | 14758460 | 14880512 | |
| PubChem | 54687 | ||
| NMRShiftDB | 70073086 | ||
| LINCS | LSM-3347 | ||
| Nikkaji | J139.432K | ||
| BindingDB | 20688 | ||
| EPA CompTox Dashboard | DTXSID6023498 | ||
| LipidMaps | LMFA05000695 | ||
| DrugCentral | 2239 | ||
| Metabolights | MTBLC63618 | ||
| Brenda | 229809 | 11499 | 229808 |
| ChemicalBook | CB92544321 | ||
| Guide to Pharmacology | 2953 | ||
| rxnorm | PRAVASTATIN SODIUM | PRAVACHOL | PRAVASTATIN |
| KEGG Ligand | C01844 | ||
| ChEBI | 63618 | ||
| ZINC | ZINC000003798763 |
